A. J. Yates

2.5k total citations
57 papers, 1.9k citations indexed

About

A. J. Yates is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, A. J. Yates has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Cell Biology. Recurrent topics in A. J. Yates's work include Glycosylation and Glycoproteins Research (18 papers), Glioma Diagnosis and Treatment (9 papers) and Neuroblastoma Research and Treatments (6 papers). A. J. Yates is often cited by papers focused on Glycosylation and Glycoproteins Research (18 papers), Glioma Diagnosis and Treatment (9 papers) and Neuroblastoma Research and Treatments (6 papers). A. J. Yates collaborates with scholars based in United States, Canada and United Kingdom. A. J. Yates's co-authors include Ronald L. Whisler, Jonathan L. Finlay, Dorothea K. Thompson, James M. Boyett, Dennis K. Pearl, J. Russell Geyer, Ronald W. Hart, Salvatore Bertolone, Jeffrey H. Wisoff and Carl P. Boesel and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

A. J. Yates

57 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. Yates United States 22 972 650 629 275 244 57 1.9k
Ángel Pestaña Spain 26 1.1k 1.1× 393 0.6× 460 0.7× 74 0.3× 168 0.7× 79 2.0k
Lin Pei United States 24 1.3k 1.3× 296 0.5× 225 0.4× 396 1.4× 226 0.9× 48 2.6k
Tatsuo Morimura Japan 20 611 0.6× 213 0.3× 138 0.2× 175 0.6× 76 0.3× 46 1.2k
Andrew S. Venteicher United States 16 2.4k 2.5× 468 0.7× 179 0.3× 149 0.5× 119 0.5× 53 3.5k
Catherine L. Cioffi United States 15 742 0.8× 316 0.5× 71 0.1× 140 0.5× 46 0.2× 27 1.7k
Jörg Cammenga Sweden 26 1.2k 1.3× 393 0.6× 117 0.2× 310 1.1× 131 0.5× 65 2.4k
Marion Jeanne United States 16 1.4k 1.4× 145 0.2× 206 0.3× 264 1.0× 143 0.6× 23 2.1k
Satoru Osuka Japan 21 677 0.7× 390 0.6× 74 0.1× 166 0.6× 82 0.3× 42 1.3k
R P Castleberry United States 23 1.2k 1.3× 213 0.3× 2.1k 3.3× 66 0.2× 110 0.5× 36 2.7k
Ana C. deCarvalho United States 25 1.1k 1.2× 481 0.7× 62 0.1× 163 0.6× 199 0.8× 44 2.0k

Countries citing papers authored by A. J. Yates

Since Specialization
Citations

This map shows the geographic impact of A. J. Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Yates more than expected).

Fields of papers citing papers by A. J. Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Yates. The network helps show where A. J. Yates may publish in the future.

Co-authorship network of co-authors of A. J. Yates

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Yates. A scholar is included among the top collaborators of A. J. Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Yates. A. J. Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oblinger, Janet L., Dennis K. Pearl, Thomas W. Prior, et al.. (2006). Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients. Neuropathology and Applied Neurobiology. 32(4). 410–418. 17 indexed citations
2.
Dasgupta, Somsankar, et al.. (2006). Endogenous GD3 ganglioside induces apoptosis in U‐1242 MG glioma cells. Journal of Neurochemistry. 96(5). 1301–1314. 21 indexed citations
3.
Oblinger, Janet L., et al.. (2006). TRAIL-Induced Apoptosis in U-1242 MG Glioma Cells. Journal of Neuropathology & Experimental Neurology. 65(2). 152–161. 8 indexed citations
4.
El‐Abbadi, Mohga, et al.. (2001). Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse. British Journal of Cancer. 85(2). 285–292. 15 indexed citations
5.
Guan, Zhen, et al.. (1999). Mechanisms through which PDGF alters intracellular calcium levels in U-1242 MG human glioma cells. Neurochemistry International. 35(6). 411–422. 6 indexed citations
6.
Rampersaud, Arfaan, James R. Van Brocklyn, & A. J. Yates. (1998). GM1 Activates the MAP Kinase Cascade Through a Novel Wortmannin‐Sensitive Step Upstream from c‐Rafa. Annals of the New York Academy of Sciences. 845(1). 424–424. 1 indexed citations
7.
Finlay, Jonathan L., Stewart Goldman, Mitchell S. Cairo, et al.. (1996). Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.. Journal of Clinical Oncology. 14(9). 2495–2503. 152 indexed citations
8.
Sung, Ching‐Ching, Dennis K. Pearl, Stephen W. Coons, et al.. (1996). Glycolipids and myelin proteins in human oligodendrogliomas. Glycoconjugate Journal. 13(3). 433–443. 26 indexed citations
9.
Lee, Ming‐Chieh, et al.. (1995). Gangliosides have a bimodal effect on DNA synthesis in U‐1242 MG human glioma cells. Journal of Neuroscience Research. 41(4). 491–500. 5 indexed citations
10.
Walters, John D., et al.. (1995). Gangliosides inhibit PDGF-induced signal transduction events in U-1242 MG human glioma cells. Neurochemical Research. 20(11). 1389–1395. 9 indexed citations
11.
Finlay, Jonathan L., James M. Boyett, A. J. Yates, et al.. (1995). Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.. Journal of Clinical Oncology. 13(1). 112–123. 256 indexed citations
12.
Singh, Lakhveer, Dennis K. Pearl, P. Spring, et al.. (1994). Neutral glycolipid composition of primary human brain tumors. Molecular and Chemical Neuropathology. 21(2-3). 241–57. 8 indexed citations
13.
Pearl, Dennis K., et al.. (1994). Patterns of reactivity with anti‐glycolipid antibodies in human primary brain tumors. Journal of Neuroscience Research. 39(2). 148–158. 11 indexed citations
14.
Pearl, Dennis K., et al.. (1993). A Review and Predictive Models of Gang ioside Uptake by Biological Membranes. Journal of Neurochemistry. 61(2). 395–441. 100 indexed citations
16.
Weiss, A P & A. J. Yates. (1992). IRREDUCIBLE DORSAL INTERPHALANGEAL GREAT TOE DISLOCATION. Orthopedics. 15(4). 480–482. 15 indexed citations
17.
Clendenon, Nancy R., Rolf F. Barth, Wanda A. Gordon, et al.. (1990). Boron neutron capture therapy of a rat glioma. Neurosurgery. 26(1). 47–47. 49 indexed citations
18.
Wilson, Morgan S., et al.. (1989). The Effects of rHuIFN-αA/D on Brain Lipids and Behavior of Neonatal ICR Swiss Albino Mice. Journal of Interferon Research. 9(1). 11–21. 1 indexed citations
19.
Yates, A. J. & Ali Ahmed. (1988). Apocrine carcinoma and apocrine metaplasia. Histopathology. 13(2). 228–231. 9 indexed citations
20.
Yates, A. J.. (1988). Glycolipids and gliomas. A review.. PubMed. 8(3). 157–80. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026